Stay updated with breaking news from Nasdaq Vtgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) will be issuing its quarterly earnings data after the market closes on Tuesday, February 13th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) last posted its earnings results on Thursday, November 9th. The company reported […]
Jefferies Financial Group upgraded shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) from a hold rating to a buy rating in a research report report published on Thursday morning, Marketbeat reports. They currently have $15.00 price objective on the stock. VTGN has been the topic of a number of other research reports. William Blair restated […]
Stifel Nicolaus initiated coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm issued a buy rating and a $12.00 price target on the stock. Separately, Maxim Group reiterated a buy rating and issued a $30.00 price target on shares of Vistagen […]
Maxim Group upgraded shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) from a hold rating to a buy rating in a report published on Monday, Marketbeat reports. Maxim Group currently has $30.00 price target on the stock. Vistagen Therapeutics Stock Down 43.1 % Shares of Vistagen Therapeutics stock traded down $5.63 on Monday, reaching $7.42. […]
Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) will announce its earnings results after the market closes on Thursday, August 10th. Vistagen Therapeutics Price Performance Shares of VTGN stock traded down $0.02 on Wednesday, hitting $7.40. 5,328,907 shares of the stock traded hands, compared to its average volume of 644,803. The company has a market capitalization […]